| Value | ₹32.00 Cr |
|---|
NSE filing, NSE: PGHL. Summary written from the filing by ALFA Finder's alert engine.
Procter & Gamble Health Ltd: key numbers
- Share price
- ₹5,605.00
- Market cap
- ₹9,304 Cr
- Revenue (annual)
- ₹1,408 Cr
- Net profit (annual)
- ₹326.9 Cr
- P/E (TTM)
- 24.5×Sector 42.0×
- Promoter holding
- 51.82%+0.00% QoQ
- FII holding
- 6.43%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Procter & Gamble Health Ltd
All →Procter & Gamble Health Results Update
P&G Health's Q2 sales grew 18% to ₹376 crore and PAT rose 26% to ₹112 crore. Growth driven by brand strength and retail execution.
Procter & Gamble Health Q2 FY27 Results: Net Profit ₹111.5 Cr, Up 26.0% YoY
Procter & Gamble Health Ltd reported revenue from operations of ₹382.5 Cr (+17.7% YoY) and net profit of ₹111.5 Cr (+26.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹111.5 Cr · +26.0% YoY
Procter & Gamble Health Board Meeting Date
Procter & Gamble Health Limited will hold a board meeting on November 2, 2026, to consider and approve the unaudited financial results for the quarter ending September 30, 2026.
Procter & Gamble Health Other Announcement
Procter & Gamble Health informed shareholders about an extended SEBI-mandated special window for re-lodging rejected physical share transfer requests until February 4, 2027.
Procter & Gamble Health Management Change
Procter & Gamble Health shareholders approved the re-appointment of Mr. S. Madhavan as an Independent Director for a five-year term starting November 15, 2026.
- Execution
- 5 years
Procter & Gamble Health Annual General Meeting
Procter & Gamble Health held its 59th Annual General Meeting on September 3, 2026, where shareholders discussed financial results and directorial appointments.
Other merger & restructuring announcements
All →Eiko Lifesciences Merger & Restructuring
Eiko Lifesciences' wholly owned subsidiary Eiko Scientific Solutions LLP will form a 50:50 joint venture, Oval Eiko Resources, with Oval Projects Engineering. The JV targets compressed bio gas production and distribution.
Welspun Enterprises Merger & Restructuring Worth ₹339.4 Cr
Welspun Enterprises completed the final tranche sale of its 51% stake in associate NXT Infra MCP to NXT-Infra Trust for about ₹339.38 Crore. NXT Infra MCP ceases to be an associate of the company.
- Value
- ₹339.4 Cr
Rashi Peripherals Merger & Restructuring
Rashi Peripherals' board approved a share purchase and shareholders' agreement to sell 26% of subsidiary Rashi Semiconductor Solutions to Restar Corporation, Japan. Execution remains subject to approvals.
Span Divergent Merger & Restructuring Worth ₹5 Cr
Span Divergent's board approved selling its Mumbai immovable property to Glorious Sales LLP, an unrelated buyer, for up to Rs.5 Crore. Completion is expected by March 31, 2027.
- Value
- ₹5.00 Cr
- Execution
- Agreement to be executed on or before March 31, 2027; sale expected to complete on or before March 31, 2027
Sunteck Realty Merger & Restructuring Worth ₹0.01 Cr
Sunteck Realty incorporated a wholly owned subsidiary, Eminara Real Estates Private Limited. The Rs 1 lakh subscription is a small real estate expansion step.
- Value
- ₹0.01 Cr
Enviro Infra Engineers Merger & Restructuring Worth ₹0.01 Cr
Enviro Infra Engineers Limited, through its step-down subsidiary arrangement, incorporated WINDAXIS RENEWABLES PRIVATE LIMITED, a renewable power venture, with Rs.0.01 Crore cash consideration for 51% stake. The new entity will pursue wind, hydro and biomass power projects.
- Value
- ₹0.01 Cr